Must Reads In Cardiology
Cardiology for May/June 2016
Hypertensive Urgency in an Outpatient Setting, JAMA Intern Med; ePub 2016 Jun 13; Patel, Young, et al
Liraglutide & CV Outcomes in Patients with T2D, N Engl J Med; ePub 2016 Jun 13; Marso, Daniels, et al
Can Empagliflozin Slow Progression of Kidney Disease?, N Engl J Med; ePub 2016 Jun 14; Wanner, Inzucchi, et al
BP Target in Patients with Acute Cerebral Hemorrhage, N Engl J Med; ePub 2016 Jun 8; Qureshi, Palesch, et al
FDA Approves Combo Drug for Treatment of Hypertension, Allergan news release; 2016 Jun 6
Cardiology for March/April 2016
Aspirin Use Guidelines for Prevention of CV & CRC, Ann Intern Med; ePub 2016 Apr 12; Bibbins-Domingo, et al
Knowledge Gaps in Cardiovascular Care of Older Adults, Circulation; ePub 2016 Apr 11; Rich, Chyun, et al
BMI in Adolescence & CV Death in Adulthood, N Engl J Med; ePub 2016 Apr 13; Twig, Yaniv, et al
Cholesterol Lowering in Intermediate-Risk Persons, N Engl J Med; ePub 2016 Apr 2; Yusuf, Bosch, et al
FDA Adds New Warnings to Diabetes Meds for HF Risk, FDA press release; 2016 Apr 5
Cardiology for January/February 2016
Normal-Weight Central Obesity & Mortality Risk, Evaluating older adults with CAD
Remote Monitoring of Patients with Heart Failure, Effectiveness after discharge studied
Acute Myocardial Infarction in Women, AHA statement examines sex-specific differences
PPIs and the Risk of Chronic Kidney Disease, What is the association?
Antithrombotic Therapy for VTE Disease, Updated guidelines for VTE treatment
Cardiology for November/December 2015
Cholesterol Treatment Eligibility & Medication Use, Prevalence among US adults examined
Normal-Weight Central Obesity & Mortality, How it compares to BMI-defined obesity
Cardiorespiratory Fitness and Obesity, Identifying men at increased mortality risk
Coffee Consumption and Risk of Mortality, How many cups are too many?
Walnut Ingestion and Diet Quality, Effects on body composition, cardiac risk studied
Cardiology for September/October 2015
Screening for High Blood Pressure, USPSTF updates guidelines
Insulin Dose and Cardiovascular Mortality, Does intensive T2D treatment heighten CV risk?
FDA Approves Praxbind as Reversal Agent, Drug reverses effects of dabigatran
Physical Activity and Heart Failure Risk, Examining the dose response relationship
Cardiac Troponin in Patients with ACS, Can hospital admissions be reduced?